Chinese patent medicine for treating sequelae of cerebral infarction and preparation method thereof

A technology for cerebral infarction sequelae and Chinese patent medicine, applied in the field of medicine, can solve the problems of insignificant curative effect, obvious side effects, drug resistance of patients, etc., and achieve the effects of no toxic and side effects, stable drug effect, and good brain environment.

Inactive Publication Date: 2016-05-04
HENAN UNIV OF CHINESE MEDICINE
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to solve the problems of existing Western medicine in the treatment of cerebral apoplexy sequelae, such as single target, easy to cause drug resistance,...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1: The Chinese patent medicine for the treatment of sequelae of cerebral infarction is prepared from the following raw materials: Rehmannia glutinosa 12 grams, Morinda officinalis 10 grams, Rhizoma Chuanxiong 12 grams, Hirudo 12 grams, Rhubarb 6 grams, Radix Astragali 10 grams, Shichangpu 10 grams, borneol 3 grams.

[0037] A preparation method of a Chinese patent medicine for treating sequelae of cerebral infarction, the preparation method is as follows:

[0038] Step 1), take rehmannia glutinosa, Morinda officinalis, Rhizoma Chuanxiong, leeches, rhubarb, astragalus, calamus calamus, and borneol according to the weight of the raw materials described in any one of claims 1 to 3, and rehmannia glutinosa, Morinda officinalis, Rhizoma chuanxiong , leech, rhubarb, astragalus, and calamus are mixed and pulverized into fine powder, and the fine powder is passed through a 100-mesh sieve to obtain a powder mixture, and borneol is pulverized to obtain borneol powder and ...

Embodiment 2

[0045] Embodiment 2: The Chinese patent medicine for the treatment of cerebral infarction sequelae is prepared from the following raw materials: Rehmannia glutinosa 18 grams, Morinda officinalis 15 grams, Rhizoma Chuanxiong 18 grams, leech 18 grams, rhubarb 12 grams, astragalus 15 grams, Shichangpu 15 grams, borneol 6 grams. The subsequent specific preparation method is consistent with that of Example 1 and will not be repeated here.

Embodiment 3

[0046] Example 3: The Chinese patent medicine for the treatment of sequelae of cerebral infarction is prepared from the following raw materials: 10 grams of Rehmannia glutinosa, 8 grams of Morinda officinalis, 10 grams of Rhizoma Chuanxiong, 10 grams of leech, 4 grams of rhubarb, 8 grams of astragalus, 8 grams of calamus and 2 grams of borneol. The subsequent specific preparation method is consistent with that of Example 1, and will not be repeated here.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicines and in particular relates to a Chinese patent medicine for treating sequelae of cerebral infarction, which can basically promote the recovery of the nerve functions of patients suffering from cerebral apoplexy hemiplegia, improve the living conditions of the patients and increase the living ability of the patients by taking multiple traditional Chinese medicinal materials as raw materials, as well as a preparation method thereof. The Chinese patent medicine is prepared from the following raw materials in parts by weight: 10-15 parts of prepared rehmannia root, 8-12 parts of morinda root, 10-15 parts of chuanxiong rhizome, 10-15 parts of leech, 4-10 parts of rhubarb, 8-12 parts of astragalus root, 8-12 parts of rhizoma acori graminei, 2-5 parts of borneol and 10-15 parts of talcum powder. The Chinese patent medicine is stable in medicine effect and directly acts on a focus through blood and blood vessels simultaneously to improve damaged brain cells and protect undamaged cells to create a favorable intracerebral environment, thereby achieving the effects of preventing thrombosis again and preventing the blood vessels from being clogged again by atheromatous plaque.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a Chinese patent medicine which can effectively treat sequelae of cerebral infarction by using various Chinese medicinal materials as raw materials and a preparation method thereof. Background technique [0002] The sequelae of cerebral infarction generally refer to the sequelae of stroke. Stroke is the name of a disease in traditional Chinese medicine, and it is also the collective and common name for acute cerebrovascular diseases. This disease is a group of diseases whose main clinical manifestations are cerebral ischemia and hemorrhagic injury. Also known as stroke or cerebrovascular accident, it has a very high mortality rate and disability rate, and is mainly divided into hemorrhagic stroke (cerebral hemorrhage or subarachnoid hemorrhage) and ischemic stroke (cerebral infarction, cerebral thrombosis ) two categories. The early mortality rate of hemorrhagic stroke is ver...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/888A61P9/10A61P7/02A61K35/62A61K31/045
CPCA61K36/804A61K9/2009A61K31/045A61K35/62A61K36/236A61K36/481A61K36/708A61K36/746A61K36/888A61K2236/331A61K2236/39A61K2236/53A61K2300/00
Inventor 张金生胡超然王剑锋张宝霞何庆勇张阳阳孙晓培
Owner HENAN UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products